STARK disclosed information through the SET Electronic Listed Companies Information Disclosure (ELCID) regarding the change in the use of proceeds from its capital fundraising by allocating 5.58 billion
Change 2018 2017 Amount % 2018 2017 Amount % Gross Profit 110.85 114.15 -3.30 -3% 109.23 112.24 -3.00 -3% Profit (Owners of the parent) 9.48 18.63 -9.15 -49% 12.59 23.16 -10.57 -46% Total Comprehensive
as of second quarter of 2018 per following table: (THB) Million 2Q18 2Q17 1H18 1H17 Total Revenues 126.04 134.25 268.92 269.05 Total Expenses 112.28 120.19 244.51 244.87 Shares of Profits 4.59 11.96
showed no significant change comparing to the same period of the year before. Total Expenses: The figure of THB (120.99) M in 3Q19 was very similar to THB (120.70) M of 3Q18, where the period of 9 months
Results Details Financial Statements for the year ended 31 December 2017 31 December 2018 Change Million Baht % Million Baht % Million Baht % Service income 151.53 99.79% 153.89 99.10% 2.36 1.56% Other
Company registered total sales revenue of THB 374.35 million and THB 202.23 million respectively or equivalent to a slump of 45.98% year on year. Domestic sales revenue declined 42.87% compared to the same
granted a license from China Food and Drug Administration (CFDA) during the beginning of 2018 as the Company had to redesign and adjust product packaging according to the granted license as well as change
Consolidated financial statements Change Increase/(Decrease) For Three Months Period Ended 30 September 2017 2018 THB mm % THB mm % THB mm % Sale Revenue Revenue from selling product under Company’s trademark 1
performance of the Group Unit: Million Baht Q3’ 2019 Q3’ 2018 Increase (decrease) Variance (%) Total revenues 1,701 1,875 (174) (9%) Net profit 112 137 (25) (18%) The Group’s total revenues for the third
change of operating performance of the company more than 20% as follow: Revenue Total Revenue of the Company and subsidiaries Total Revenue of the Company and subsidiaries the quarter ended September 30